Baxter International Inc. (BAX)
Baxter International Inc. (BAX) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $25.78, up 0.92% on the day, which values the company at $13.33B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.
Key facts
- Share price
- $25.78+0.92% today
- Market value
- $13.33B
- Forward P/E
- 12.6×
- Dividend yield
- 0.16%
- Funk Score
- 27/100
- Against its own history
- Well below its usual priceusual price $52.62
- 200-week average
- $31.6419% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Baxter International Inc. in more detail
BAX trades at 12.6× next year's expected earnings, 1.1× sales. Measured against its own history, the price is 51% below what its usual multiples would imply ($52.62) — well below its usual price. It sits 19% below its 200-week average of $31.64.
Over the last five fiscal years Baxter International Inc. has compounded revenue -0.7% a year, free cash flow -22.5% a year. Its Funk Score is 27 out of 100 (financial strength 1.8, profitability 1.8, growth 3.0, value 4.3, each out of 10).
Worth checking: Share count keeps rising; Thin interest cover.
6 of the superinvestors tracked here hold BAX, including Richard Pzena (4.4% of the portfolio), Edgar Wachenheim (3.7% of the portfolio), Steven Romick (2.2% of the portfolio).
Superinvestors holding BAX
6 of the investors tracked here report a position in their latest 13F filing.
- Richard Pzena Pzena Investment Management4.39% of portfolio · $1.5B · trimmed · Q3 2026
- Edgar Wachenheim Greenhaven Associates3.74% of portfolio · $297.5M · trimmed · Q3 2026
- Steven Romick First Pacific Advisors (FPA)2.21% of portfolio · $185.4M · added · Q3 2026
- Dodge & Cox team Dodge & Cox0.72% of portfolio · $1.3B · trimmed · Q3 2026
- Boaz Weinstein Saba Capital Management0.15% of portfolio · $4.8M · trimmed · Q2 2026
- Tweedy, Browne team Tweedy, Browne Company0.02% of portfolio · $227.5K · Q3 2026
Health Care companies of similar size
- BridgeBio PharmaBBIO
- Summit TherapeuticsSMMT
- GlaukosGKOS
- Encompass HealthEHC
- BrightSpring Health ServicesBTSG
- Elanco Animal HealthELAN
- Smith & NephewSNN
- PenumbraPEN
- Dr. Reddy's LaboratoriesRDY
- Align TechnologyALGN
- Cooper CompaniesCOO
- Fresenius Medical CareFMS
Side by side:BAX vs BTSG (Baxter International Inc. vs BrightSpring Health Services)BAX vs EHC (Baxter International Inc. vs Encompass Health)BAX vs ELAN (Baxter International Inc. vs Elanco Animal Health)BAX vs GKOS (Baxter International Inc. vs Glaukos)BAX vs SNN (Baxter International Inc. vs Smith & Nephew)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Baxter International Inc. (BAX): questions and answers
What is BAX's PEG ratio?
Baxter International Inc.'s PEG ratio is 36.68 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Baxter International Inc.'s market cap?
Baxter International Inc. is valued at $13.33B at a share price of $25.78.
Is BAX overvalued or undervalued?
Against its own history, BAX is well below its usual price: the price is 51% below the $52.62 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is BAX above its 200-week moving average?
No. BAX is 18.5% below its 200-week average of $31.64. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Baxter International Inc. growing?
Over the last five fiscal years Baxter International Inc.'s revenue grew -0.7% a year; over ten years revenue grew 1.2% a year.
Does BAX pay a dividend?
Yes. Baxter International Inc.'s dividend yield is 0.16%, or $0.04 a share a year, paying out 155% of earnings.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Baxter International Inc. (BAX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BAX
Underlying data: Yahoo Finance; company filings with the SEC.